TEAM Technologies is expanding its medical device capabilities to include front-end design and innovation. The company announced the acquisition of TAG3 Engineering, a Florida-based design, development, and manufacturing firm that adds these capabilities to TEAM’s existing manufacturing operations.
Key Points
- TEAM Technologies acquired TAG3 Engineering LLC, a design, development, and manufacturing firm located in Sunrise, Florida, on September 17, 2025. Financial terms were not disclosed.
- TAG3 provides services across the medical device development process, including front-end design, engineering, regulatory, verification and validation testing, and manufacturing. The company works with physicians, entrepreneurs, and large medical device OEMs.
- The firm’s experience spans eight therapeutic areas: cardiovascular, neurovascular, structural heart, peripheral vascular, stroke, glaucoma, gastrointestinal, and urological devices.
- TAG3 operates an ISO 13485-certified and FDA 21 Part 820-compliant quality system. The facility includes Class 7 and Class 8 clean rooms, testing and simulation labs, 3D printing, and electrospinning equipment.
- The acquisition aims to complement TEAM Technologies’ existing capabilities in scaling products from concept to commercialization, though specific integration plans were not provided.
The addition of TAG3’s design capabilities may provide TEAM Technologies with earlier entry into customer relationships during the product development phase, potentially creating a more complete service offering for medical device manufacturers.
The Data
- TAG3 operates a 16,000 square foot facility in Sunrise, Florida, equipped for design, development, and manufacturing operations.
- The facility maintains GMP-compliant Class 7 and Class 8 clean rooms, along with testing and simulation laboratories.
- TEAM Technologies has locations throughout the United States, with international facilities in Mexico and Singapore, though the total number of facilities was not specified.
Industry Context
TAG3’s medical device development and front-end innovation capabilities dovetail well with TEAM Tech’s existing core capabilities of taking an idea from concept and scaling it to commercialization.
Marshall White, President and CEO at TEAM Technologies
TEAM Technologies describes itself as a leading end-to-end outsourced manufacturer of mission-critical medical devices, serving medical device and pharmaceutical OEMs. The company has an extensive array of advanced and vertically integrated manufacturing solutions designed to simplify customer supply chains.
TAG3 Engineering focuses on partnering with inventors, startups, and medical device companies to accelerate device design and development. The company states it can address needs across all phases of the medical device lifecycle, from initial concept through commercialization, though specific case studies or success metrics were not provided in the announcement.
Matt Altman, a Managing Partner at Arlington Capital Partners, noted the acquisition enhances what he described as TEAM Technologies’ “fast-growing minimally invasive surgical franchise.” The strategic rationale appears centered on offering customers a broader range of services under one provider, though whether this translates to competitive advantage remains to be demonstrated in practice.
